Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1923 1
1973 1
1974 3
1975 1
1976 1
1980 2
1984 1
1985 1
1986 1
1988 2
1989 3
1990 4
1991 5
1992 5
1993 7
1994 6
1995 4
1996 3
1997 6
1998 2
1999 1
2000 3
2001 1
2003 1
2004 1
2005 2
2007 1
2008 2
2009 2
2010 1
2011 2
2012 2
2013 4
2014 1
2015 4
2016 2
2017 3
2018 3
2019 2
2020 3
2021 6
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

106 results
Results by year
Filters applied: . Clear all
Page 1
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Among authors: mittra i. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Is inflammation a direct response to dsDNA breaks?
Chaudhary S, Raghuram GV, Mittra I. Chaudhary S, et al. Among authors: mittra i. Mutat Res. 2018 Mar;808:48-52. doi: 10.1016/j.mrfmmm.2018.02.002. Epub 2018 Feb 22. Mutat Res. 2018. PMID: 29518635
106 results